
Globus Medical, Inc.
GMED
Updated: 22/09/2026, 15:10:37
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
No summaries found.
- Share price
- $74.29
- Market cap
- $10.02B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Keith W. Pfeil
- Employees
- 6,000
- IPO date
- 03/08/2012
- Beta
- 0.956
- Last dividend
- $0.00
- Day range
- $73.59 – $74.41
- 52-week range
- $54.15 – $101.40
- 1-day performance
- 0.28%
- 1-year performance
- 37.19%
- Current drawdown (1Y)
- -26.74%
- CIK
- 0001237831
- CUSIP
- 379577208
- ISIN
- US3795772082
- Created
- 07/12/2025, 04:22:17
- Last update
- 22/09/2026, 15:10:37
Track Globus Medical, Inc. with an AI analyst
See which prediction-market events move GMED, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
Zacks Investment Research • STOCK • 09/06/2026, 13:06:00
Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?
Zacks Investment Research • STOCK • 08/06/2026, 12:56:34
GMED or PEN: Which Is the Better Value Stock Right Now?
Zacks Investment Research • STOCK • 05/06/2026, 14:40:28
Here's How Financial Strength Remains a Key Advantage for GMED
Zacks Investment Research • STOCK • 04/06/2026, 14:55:28
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
Zacks Investment Research • STOCK • 02/06/2026, 13:30:28
GMED's Robotics Leasing Shift Could Build Recurring Revenue
Zacks Investment Research • STOCK • 29/05/2026, 12:55:31
Looking for a Growth Stock? 3 Reasons Why Globus Medical (GMED) is a Solid Choice
Zacks Investment Research • STOCK • 27/05/2026, 15:46:18
Globus Medical (GMED) Upgraded to Strong Buy: Here's What You Should Know
Zacks Investment Research • STOCK • 27/05/2026, 15:01:17
GMED vs. SONVY: Which Stock Is the Better Value Option?
Zacks Investment Research • STOCK • 20/05/2026, 14:40:26
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Zacks Investment Research • STOCK • 20/05/2026, 12:40:27
3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)
Zacks Investment Research • STOCK • 11/05/2026, 15:46:07
Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED)
Zacks Investment Research • STOCK • 11/05/2026, 12:35:30